Patents by Inventor Michael T. Hogan

Michael T. Hogan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200080146
    Abstract: Provided are methods for amplifying a gene or RNA or sets thereof of interest using a tandem PCR process. The primers in the first PCR or set of PCR reactions are locus-specific. The primers in the second PCR or set of PCR reactions are specific for a sub-sequence of the locus-specific primers and completely consumed during the second PCR amplification. For RNA amplification, the first PCR is reverse transcription and the resulting cDNA(s) provide a template for cRNA synthesis, endpoint PCR or real time PCR. Also provided is a tandem PCR method which accepts raw, completely unpurified mouthwash, cheek swabs and ORAGENE-stabilized saliva as the sample input, the resulting amplicons serving as the substrate for complex, microarray-based genetic testing. Also provided is a method of allelotyping a gene or set thereof by amplifying the gene(s) using tandem PCR on DNA or RNA comprising the sample.
    Type: Application
    Filed: July 1, 2019
    Publication date: March 12, 2020
    Applicant: GENOMICS USA, INC.
    Inventors: Michael E. Hogan, Georgina Lopez Padilla, Melissa R. May, Andrew T. Abalos, Frederick H. Eggars, Kevin M. O'Brien
  • Patent number: 10337066
    Abstract: Provided are methods for amplifying a gene or RNA or sets thereof of interest using a tandem PCR process. The primers in the first PCR or set of PCR reactions are locus-specific. The primers in the second PCR or set of PCR reactions are specific for a sub-sequence of the locus-specific primers and completely consumed during the second PCR amplification. For RNA amplification, the first PCR is reverse transcription and the resulting cDNA(s) provide a template for cRNA synthesis, endpoint PCR or real time PCR. Also provided is a tandem PCR method which accepts raw, completely unpurified mouthwash, cheek swabs and ORAGENE-stabilized saliva as the sample input, the resulting amplicons serving as the substrate for complex, microarray-based genetic testing. Also provided is a method of allelotyping a gene or set thereof by amplifying the gene(s) using tandem PCR on DNA or RNA comprising the sample.
    Type: Grant
    Filed: August 15, 2016
    Date of Patent: July 2, 2019
    Assignee: Genomics USA, Inc.
    Inventors: Michael E. Hogan, Georgina Lopez Padilla, Melissa R. May, Andrew T. Abalos, Frederick H. Eggars, Kevin M. O'Brien
  • Patent number: 7814368
    Abstract: Power consumption that occurs in response to software errors may be reduced. In one example a system tracks a number of occurrences a first set of code causes a system to perform one or more reset actions, determines whether the number of occurrences exceeds a threshold, and selects a second set of code to execute in place of the first set of code, if the quantity exceeds the threshold.
    Type: Grant
    Filed: February 8, 2007
    Date of Patent: October 12, 2010
    Assignee: G2 Microsystems Pty. Ltd.
    Inventors: Michael T. Hogan, Thomas McDermott
  • Publication number: 20080155323
    Abstract: Power consumption that occurs in response to software errors may be reduced. In one example a system tracks a number of occurrences a first set of code causes a system to perform one or more reset actions, determines whether the number of occurrences exceeds a threshold, and selects a second set of code to execute in place of the first set of code, if the quantity exceeds the threshold.
    Type: Application
    Filed: February 8, 2007
    Publication date: June 26, 2008
    Inventors: Michael T. Hogan, Thomas McDermott